Aytu BioPharma, Inc.

ACTIVE

7900 E Union Ave Ste 920, 科罗拉多州阿拉珀霍县, 科罗拉多州, United Stateswww.aytubio.comPublic150 employeesEstablished: 2002-01-01

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2002

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

33.3%

Not Applicable

16.7%

Phase 3

16.7%

Phase 4

16.7%

Trial Status Distribution

Active, not recruiting

33.3%

Suspended

16.7%

Withdrawn

50.0%

Clinical Trials

Trials sponsored by this organization (6)

A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0

Withdrawn

observational

Sep 2025

Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.

Phase 3

Suspended

interventional

Jan 2025260 participants

Respiratory COVID-19: A Randomized, Sham-Controlled Study

A study to investigate the efficacy, safety, and pharmacokinetics (PK) of enzastaurin for the prevention of arterial events in patients with vEDS confirmed with COL3A1 mutations

Phase 1

Active, not recruiting

Apr 2022260 participants

A study to investigate the efficacy, safety, and pharmacokinetics of enzastaurin for the prevention of arterial events in patients with vEDS confirmed with COL3A1 mutations

Phase 1

Active, not recruiting

interventional

Apr 2022260 participants

ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

METADATE CD

FDA

2023-10-31

News

No news articles found

Back to Organizations